Advertisment
 

Join the Topix community today: 

Sign Up

 | 

Sign In

Medication

May 12, 2008

New Study Demonstrates Actemra (tocilizumab) Inhibits Progression of...

“At one year, the results from the LITHE trial clearly demonstrate that ACTEMRA could be an effective component in the battle against the long-term debilitating effects of RA, including joint damage and loss of physical function”

Roche today announced one-year results from a new two-year Phase III study showing that ACTEMRA can significantly inhibit progression of structural damage to joints in patients with rheumatoid arthritis , a ... via Med Ad News

Leave a Comment

Comments

Type in your comments to post to the forum
Name
(appears on your post)
Comments
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Medication Discussions
Topic Updated Last By Comments
Fun in the sun is good but remember to protect ... 26 min Jolyn 1
FDA Warns About Cipro, Other Antibiotics 1 hr 49ravens 9
Opioid Addiction: No Reason to Withhold Pain Ma... 1 hr MATsavesLIVES 24
Phentermine for weight loss 1 hr Dee 1580
Ask Dr. Weil by Andrew Weil : Red yeast rice ex... 2 hr Claire 3
Helping America Reduce Methadone Deaths 2 hr MATsavesLIVES 3
Could Watermelon Replace Viagra? 3 hr Ben 44